R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams.

In this webinar, taking place on October 27, 2026, hosted by DDW and supported by Benchling, you’ll learn how R&D is moving beyond chat toward multi-agent collaboration, with teams of AI agents that work together on your workflows, grounded in your scientific context and built on leading scientific intelligence. See how this is already being put into practice, and what it means for making faster, more confident decisions across your program.

This webinar will be presented by Nicholas Larus-Stone and Clare Young. Larus-Stone leads Benchling’s AI team, building the agents and models that help R&D accelerate their workflows. He founded Sphinx Bio, an AI drug discovery startup, and Bits in Bio, a community bringing together scientists and tech entrepreneurs, and now shapes how R&D teams build their agentic workflows. Young leads product for AI agents at Benchling, from the first agents that could research and draft to the ones that now work collaboratively across a full R&D program. With a decade of experience in the R&D space, she has helped global biopharma organisations bring new technology into their workflows.

This is a dual-broadcast webinar, please register for the session that suits you best:

Register for Session 1 – 10am GMT/11am CET

Register for Session 2 – 10 am PDT/1pm EDT